S&P 500

5.222,68

0,16%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Century Therapeutics Inc (IPSC)
Century Therapeutics Inc (IPSC) Notícias

IPSC

Century Therapeutics (IPSC)

Century Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:IPSC

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
10/05/2024	08:00	GlobeNewswire Inc.	Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting	NASDAQ:IPSC	Century Therapeutics Inc
09/05/2024	08:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IPSC	Century Therapeutics Inc
09/05/2024	08:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IPSC	Century Therapeutics Inc
09/05/2024	08:30	GlobeNewswire Inc.	Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates	NASDAQ:IPSC	Century Therapeutics Inc
07/05/2024	18:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IPSC	Century Therapeutics Inc
06/05/2024	17:52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IPSC	Century Therapeutics Inc
23/04/2024	08:00	GlobeNewswire Inc.	Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	NASDAQ:IPSC	Century Therapeutics Inc
11/04/2024	08:00	GlobeNewswire Inc.	Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics	NASDAQ:IPSC	Century Therapeutics Inc
08/04/2024	17:05	GlobeNewswire Inc.	Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IPSC	Century Therapeutics Inc
25/03/2024	08:00	GlobeNewswire Inc.	Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors	NASDAQ:IPSC	Century Therapeutics Inc
19/03/2024	08:00	GlobeNewswire Inc.	Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	NASDAQ:IPSC	Century Therapeutics Inc
14/03/2024	08:30	GlobeNewswire Inc.	Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates	NASDAQ:IPSC	Century Therapeutics Inc
05/03/2024	20:03	GlobeNewswire Inc.	Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IPSC	Century Therapeutics Inc
21/02/2024	15:04	Edgar (US Regulatory)	Form 144/A - Report of proposed sale of securities: [Amend]	NASDAQ:IPSC	Century Therapeutics Inc
01/02/2024	09:00	GlobeNewswire Inc.	Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:IPSC	Century Therapeutics Inc
09/12/2023	14:00	GlobeNewswire Inc.	Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits	NASDAQ:IPSC	Century Therapeutics Inc
06/12/2023	18:06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IPSC	Century Therapeutics Inc
06/12/2023	09:30	GlobeNewswire Inc.	Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus	NASDAQ:IPSC	Century Therapeutics Inc
06/12/2023	09:30	GlobeNewswire Inc.	Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus	NASDAQ:IPSC	Century Therapeutics Inc
21/11/2023	09:00	GlobeNewswire Inc.	Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:IPSC	Century Therapeutics Inc
09/11/2023	09:01	GlobeNewswire Inc.	Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates	NASDAQ:IPSC	Century Therapeutics Inc
09/11/2023	09:00	GlobeNewswire Inc.	Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer	NASDAQ:IPSC	Century Therapeutics Inc
09/11/2023	09:00	GlobeNewswire Inc.	Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases	NASDAQ:IPSC	Century Therapeutics Inc
02/11/2023	10:00	GlobeNewswire Inc.	Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and Exposition	NASDAQ:IPSC	Century Therapeutics Inc
26/09/2023	08:00	GlobeNewswire Inc.	Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference	NASDAQ:IPSC	Century Therapeutics Inc
09/08/2023	08:30	GlobeNewswire Inc.	Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates	NASDAQ:IPSC	Century Therapeutics Inc
29/06/2023	17:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IPSC	Century Therapeutics Inc
11/05/2023	08:31	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IPSC	Century Therapeutics Inc
11/05/2023	08:30	GlobeNewswire Inc.	Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates	NASDAQ:IPSC	Century Therapeutics Inc
05/05/2023	17:46	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:IPSC	Century Therapeutics Inc